ResponseStigma as a public health tool: Implications for health promotion and citizen involvement – A response to Bayer and Fairchild
Section snippets
Conflicts of interest statement
Laura Williamson: None.
Betsy Thom: In the past three years BT has been a member of ICAP research advisory group. She has attended a meeting supported by ICAP (expenses paid) and written a chapter for an ICAP book (honorarium paid).
Gerry V. Stimson: GVS was a member of the National Institute for Health Care Excellence group on the development of guidelines on tobacco harm reduction. A company of which GVS is a director received in 2012 a research feasibility grant from an electronic cigarette
References (7)
- et al.
Stigma: Time for a hard conversation
International Journal of Drug Policy
(2015) Stigma and the ethics of public health: Not can we but should we
Social Science and Medicine
(2008)- et al.
Stigma as a public health tool: Implications for health promotion and citizen involvement
International Journal of Drug Policy
(2014)
There are more references available in the full text version of this article.
Cited by (4)
Environmental Prevention: Why Do We Need It Now and How to Advance It?
2022, Journal of PreventionUnderstanding Substance Use Stigma
2021, Journal of Social Work Practice in the AddictionsConcept of problem substance use
2020, Psychiatrie (CZE)
Copyright © 2015 Elsevier B.V. All rights reserved.